Educating peers at programs and symposia about the legal and regulatory issues confronted by industry is important to Gardner Law. Topics covered relate to off-label promotion and lawful dissemination methods, social media use, implementing effective compliance programs and performing compliance audits, mobile medical applications, Sunshine reporting, enforcement (FDA, OIG, & DOJ), and the FDA approval process.
Providing quotes to the press regarding regulatory developments that impact FDA-regulated companies is important to the firm. Quotes from Mark Gardner in the past have been featured in the StarTribune, FDA News, Qmed, MD+DI (UBM Canon), Medical Device Daily (Thompson Reuters), MedCity News, Orthopedics This Week, and Medical Alley, among others.
Gardner Law periodically writes about important legal and regulatory issues that impact FDA-regulated industries. You can view past publications by clicking below. Sign up for News Alerts by scrolling to the bottom of the page.
Follow the link below for access to various resources, including the homepages of AdvaMed, PhRMA, ACCME, RAPs, MDMA, Medical Alley, CLSA, FDA, OIG, and various other government and private entities.